Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Buciak

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Transport of histone through the blood-brain barrierW M Pardridge, D Triguero, J Buciak
Journal of Neurochemistry|June 1, 1990
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteinsD Triguero, J Buciak, W M Pardridge
The Journal of Infectious Diseases|September 1, 1994
Treatment of human immunodeficiency virus-infected lymphocytes with cationized human immunoglobulinsW M Pardridge, J Buciak, J Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vectorW M Pardridge, D Triguero, J Buciak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 1995
Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complexY Saito, J Buciak, J Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the proteinW M Pardridge, J Buciak, J Yang, et al.
Journal of Neuroscience Research|July 1, 1989
Human brain microvascular DR-antigenW M Pardridge, J Yang, J Buciak, et al.
The Journal of Infectious Diseases|January 1, 1994
Enhanced endocytosis and anti-human immunodeficiency virus type 1 activity of anti-rev antibodies after cationizationW M Pardridge, U Bickel, J Buciak, et al.
Immunology Letters|October 1, 1994
Cationization of a monoclonal antibody to the human immunodeficiency virus REV protein enhances cellular uptake but does not impair antigen binding of the antibodyW M Pardridge, U Bickel, J Buciak, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Transport of histone through the blood-brain barrierW M Pardridge, D Triguero, J Buciak
Journal of Neurochemistry|June 1, 1990
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteinsD Triguero, J Buciak, W M Pardridge
The Journal of Infectious Diseases|September 1, 1994
Treatment of human immunodeficiency virus-infected lymphocytes with cationized human immunoglobulinsW M Pardridge, J Buciak, J Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vectorW M Pardridge, D Triguero, J Buciak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 1995
Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complexY Saito, J Buciak, J Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the proteinW M Pardridge, J Buciak, J Yang, et al.
Journal of Neuroscience Research|July 1, 1989
Human brain microvascular DR-antigenW M Pardridge, J Yang, J Buciak, et al.
The Journal of Infectious Diseases|January 1, 1994
Enhanced endocytosis and anti-human immunodeficiency virus type 1 activity of anti-rev antibodies after cationizationW M Pardridge, U Bickel, J Buciak, et al.
Immunology Letters|October 1, 1994
Cationization of a monoclonal antibody to the human immunodeficiency virus REV protein enhances cellular uptake but does not impair antigen binding of the antibodyW M Pardridge, U Bickel, J Buciak, et al.
Pageof 1